The structures of the S(-) and R(＋) enantiomers of BOF-4272 are shown on the left and right, respectively. The transport mechanisms of the enantiomers of BOF-4272, a new drug for the treatment of hyperuricemia, were studied using freshly prepared rat hepatocytes. BOF-4272 consists of S(-) and R(＋) enantiomers due to a chiral center in the sulfoxide moiety. The uptake of these BOF-4272 enantiomers by hepatocytes was found to be temperature and dose dependent. The temperature-dependent uptake of the S(-) and R(＋) enantiomers showed saturation kinetics. The K m values for the S(-) and R(＋) enantiomers were 59.3 and 25.7 mM, respectively, which was a signiˆcant diŠer-ence (p＜0.05). However, the maximal uptake rate was comparable for both enantiomers. Metabolic inhibitors such as antimycin, oligomycin, rotenone, carbonylcyanide m-chlorophenyl hydrazone, and carbonyl cyanide-p-(tri‰u-romethoxy)-phenylhydrazone signiˆcantly inhibited uptake of the R(＋) enantiomer, but had little eŠect on uptake of the S(-) enantiomer. Ouabain (an inhibitor of Na ＋ /K ＋ -ATPase) and p-nitrobenzylthioinosine (NBMPR, a nucleoside transporter inhibitor) showed no signiˆcant eŠects on the uptake of either enantiomer. Organic anions such as taurocholate and cholate reduced the uptake of both enantiomers. These results suggest that the hepatic uptake of both BOF-4272 enantiomers is not due to simple diŠusion but also involves carrier-mediated uptake. We suggest that the carrier-mediated uptake of BOF-4272 enantiomers includes both NBMPR-insensitive facilitated diŠusion and an active transport system in liver plasma membrane, and that the enantioselective uptake of BOF-4272 is due to diŠerences in a‹nity for the active transporter.
Fig. 1. Chemical Structure of BOF-4272
The structures of the S(-) and R(＋) enantiomers of BOF-4272 are shown on the left and right, respectively. BOF-4272, a derivative of pyrazolotriazine, is a new drug that has been developed for the treatment of hyperuricemia and ischemic reperfusion injury (Fig.  1) . [1] [2] [3] [4] BOF-4272 inhibits the de novo biosynthesis of uric acid by blocking the xanthine oxidase/xanthine dehydrogenase system, which catalyzes the last step of purine catabolism. 2, 3) The mechanism of inhibition by BOF-4272 was elucidated in an in vitro study using milk xanthine oxidase/xanthine dehydrogenase. 5) BOF-4272 signiˆcantly reduces the concentration of free radicals generated by xanthine oxidase and consequently inhibits cell necrosis. 6) It was found in previous in situ studies that the hepatic elimination of BOF-4272 was quite substantial at 37°C. [7] [8] [9] It was also demonstrated in a previous in situ study that the hepatic extraction ratio of the R(＋) enantiomer of BOF-4272 was signiˆcantly greater than that of the S (-) enantiomer in the presence of bovine serum albumin in rats. 10) Recently, we have found that the plasma concentration of the S(-) enantiomer of BOF-4272 after the intravenous and oral administration of racemic BOF-4272 in rats was signiˆcantly higher than that of R(＋)enantiomer, and that the liver concentration after oral administration of racemic BOF-4272 in rats was signiˆcantly higher for the R(＋) enantiomer than for the S(-) enantiomer of BOF-4272 (in preparation). The stereoselectivity of plasma concentrations of racemic BOF-4272 is suggested to be due to diŠerences in the hepatic uptake of the two BOF-4272 enantiomers, and/or in their biotransformation in the rat liver. In the present study, we investigated the in vitro uptake of BOF-4272 by isolated rat hepatocytes to elucidate the hepatic transport mechanism of the enantiomers of BOF-4272. METHODS
Animals
The animals used were 7-week-old male Wistar rats weighing between 200 and 250 g, purchased from Charles River Japan (Kanagawa, Japan).
Materials
The BOF-4272 used in this study was synthesized at Otsuka Pharmaceutical Factory, Inc. (Tokushima, Japan). Antimycin, oligomycin, rotenone, ouabain, sodium taurocholate (TCA),
, and trypsin inhibitor (type II-S; soybean) were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Sodium cholate (CA), p-chloromercuribenzoic acid (PCMB), and collagenase (from Clostridium histolyticum) were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Trypan blue was purchased from Flow Laboratories Ltd. (Irvine, UK). Eagle's minimum essential medium (MEM) Nissui type 1 was purchased from Nissui Pharmaceutical Co., Ltd. (Tokyo, Japan). All other chemicals and reagents used were of the highest grade available from commercial sources.
Preparation of Isolated Hepatocytes Liver perfusion was performed as described by Moldeus et al. 11) Brie‰y, the rat liver was perfused at 37°C for 4 min with Ca 2＋ -and Mg 2＋ -free Hanks' solution (pH 7.4) containing 0.5 mM ethylene glycol-bis (b-aminoethyl ether) N,N,N′ ,N′ -tetraacetic acid (EGTA) and for 6 min with Hanks' solution (pH 7.4) containing 0.1％ collagenase and 0.05％ trypsin inhibitor. Hepatocytes were liberated from the perfused liver by blunt dissection and dispersed by gentle shaking in Ca 2＋ -and Mg 2＋ -free Hanks' solution (pH 7.4). Afterˆltration through gauze, the hepatocytes were separated from nonparenchymal cells by centrifugation three times, with the cells washed and resuspended in Ca 2＋ -and Mg 2＋ -free Hanks' solution (pH 7.4) each time. Finally, the cells were resuspended in Eagle's MEM (pH 7.4) containing 0.5％ bovine serum albumin (BSA) and 2 mM L-glutamate. Cell suspensions with a viability greater than 90％ as assessed by trypan blue dye exclusion were used for experiments. The number of cells was counted using a Coulter counter. For incubation, the cell suspensions were diluted to aˆnal concentration of 2×10 6 viable cells/ml.
Uptake Studies After preincubation of 1 ml of cell suspension containing 2×10 6 viable cells/ml for 5 min at 4°C or 37°C, the reaction was started by the addition of 1 ml of the incubation medium containing BOF-4272 preincubated for 5 min at 4°C or 37°C
. The reaction time wasˆxed at 5 min except in the time-course experiments. When the eŠects of inhibitors, sulfhydryl (SH) -modifying reagents (PCMBS, PCMB), DIDS, organic anions, or BOF-4272 distomer were tested, these reagents were added to the medium 5 min before the addition of BOF-4272. After incubation for a suitable period, 1.5 ml of the reaction mixture was transferred to another tube and was centrifuged at 10,000 rpm for 10 s in a Hinac centrifuge CR15T (Hitachi Koki Co., Ltd., Tokyo, Japan) at 4°C to stop the reaction by separating the cells from the incubation medium. After centrifugation, the supernatant was transferred to another tube for measurement of lactate dehydrogenase (LDH) activity. The cells were washed twice with 1.5 ml of ice-cold phosphate-buŠered saline (PBS) (-) and dissolved by adding 1.5 ml of 0.1％ Triton X-100. After centrifugation, 0.5 ml of the supernatant was transferred to two other tubes, with one tube used to determine protein content and LDH activity and other used as the high-performance liquid chromatography (HPLC) sample. The HPLC sample was supplemented with 3 ml of ethyl acetate and agitated. After centrifugation, the ethyl acetate layer was transferred to another tube and dried under reduced pressure. The mobile phase was added to the dried sample for analysis of BOF-4272 and agitated. The dissolved sample wasˆltered through a membraneˆlter (pore size, 0.2 mm). An aliquot of 50 ml of theˆltrate was injected onto the HPLC system for analysis of BOF-4272.
Chromatography BOF-4272 concentrations were measured using an HPLC system (CCP & 8010 Series, Tosoh Co., Tokyo, Japan) with a stationary phase of TSKgel Silica-60 (250×4.6 mm i.d., Tosoh Co.) on the extraction column and two pieces of CHIRALCELL OD (50×4.6 mm i.d., Daicel Chemical Industries, Ltd., Tokyo, Japan) on the chiral separation column. The concentrations of BOF-4272 enantiomers were determined using a ‰uorescence photometer (Tosoh Co.) with excitation and emission wavelengths of 319 and 402 nm, respectively. The integrated data analyzer was a C-R4AX Chromatopac (Shimadzu Co., Kyoto, Japan). The ‰ow rate and the column temperature were 0.6 ml/min and 40°C, respectively. The mobile phase was a mixture of n-hexane, ethanol, and formic acid (650 : 350 : 4, v/v).
Protein Content
The protein content of the samples was estimated by the method of Lowry et al. 12) using BSA as the standard.
DLDH Latency
The LDH activity of the samples was measured according to the method of Bergmeyer and Bernt. 13) The LDH latency was calculated from the LDH activity of the samples dissolved with Triton X-100 and the total activity (LDH activity of the supernatant of the reaction sample plus that of the samples dissolved with Triton X-100). DLDH latency was calculated as a percentage relative to the LDH latency of controls.
Data Analysis
The kinetic parameters ( K m , V max ) of uptake were calculated from the concentration-dependence data by non linear least-squares analysis using the MULTI program, 14) by use of equation 1:
where v and s are temperature-dependent uptake rate and concentration of substance, and V max and K m are maximum uptake rate and Michaelis constant, respectively.
All experimental results are given as mean±SD, and the statistical analysis in Table 1 was performed using the paired Student's t test (two-tailed) with a signiˆcance level of p＜0.05. Figure 2 shows the time course of the uptake of BOF-4272 enantiomers by isolated hepatocytes at a substrate concentration of 5 mM. The top panel shows uptake of each enantiomer at 37°C and at 4°C. The hepatic uptake of the R(＋) enantiomer at 37°C gradually increased with time and reached a plateau up to 10 min. However, the hepatic uptake of the S(-) enantiomer at 37°C increased with time up to only 2 min. On the other hand, the hepatic uptake of either BOF-4272 enantiomer at 4°C reached a plateau within 1 min and then remained at the same level. The bottom panel of Fig. 2 shows the temperature-dependent uptake, which is calculated by the diŠerence between hepatic uptake at 37°C and that at 4°C. The temperature-dependent uptake of the R(＋) enantiomer shows high velocity and a high saturation point as compared with the S(-)enantiomer. However, the time to reach equilibrium in the temperature-dependent uptake of the R(＋) enantiomer isˆve times longer than that of the S(-) enantiomer (Fig. 2 , bot- The left and light panels show the hepatic uptake rate and percent uptake relative to the control, respectively. Experiments were performed in duplicate. Data are mean±SD of three separate experiments. The initial uptake rates of the S(-) and R(＋) enantiomers in controls were 23.1±2.3 and 50.3±6.8 pmol/mg protein/min, respectively. tom panel). The hepatic uptake rate of BOF-4272 at 37°C increased as a function of the BOF-4272 concentration in the medium, exhibiting a curvilinear pattern and enantioselectivity (data not shown). On the other hand, the hepatic uptake rate at 4°C increased in proportion to the BOF-4272 concentration in the medium, and neither the saturation pattern nor enantioselectivity was observed in the uptake of either BOF-4272 enantiomer at 4°C (data not shown). Figure 3 shows the relationship between the initial temperature-dependent hepatic uptake rate of BOF-4272 enantiomers and the substrate concentration. The closed circles and triangles are the points where the hepatic uptake rate at 4°C was subtracted from that at 37°C, and the lines are the curves of the Michaelis-Menten equation as predicted by MULTI. The kinetic parameters obtained byˆtting the data for the BOF-4272 enantiomers to the Michaelis-Menten equation using MULTI are listed Table 1 . The K m of the R(＋) enantiomer was signiˆcantly lower than that of the S(-) enantiomer (p＜0.05) , whereas the Vmax was comparable for the two enantiomers. The data show the higher a‹nity of the R(＋)enantiomer to the temperature-dependent hepatic uptake system than that of the S(-) enantiomer, indicating that the uptake rate of the R(＋) enantiomer by the hepatocytes was faster than that of the S(-)enantiomer.
RESULTS AND DISCUSSION
The eŠects of various inhibitors on the initial hepatic uptake rate of BOF-4272 at 5 mM are shown in Fig. 4 . The hepatic uptake rate of the R(＋) enantiomer was about 2.2 times higher than that of the S (-) enantiomer in controls. Metabolic inhibitors such as antimycin, oligomycin, rotenone, CCCP, and FCCP (an inhibitor of oxidative phosphorylation) 15) signiˆcantly reduced the uptake rate of the R(＋) enantiomer, but had little eŠect on the uptake rate of the S(-) enantiomer. Ouabain, an inhibitor of Na ＋ / K ＋ -ATPase, 15) had no signiˆcant eŠect on the uptake rate of either enantiomer. This indicates that the uptake system of both enantiomers is ATP dependent and Na ＋ independent. Since the structure of BOF-4272 resembles that of xanthine, BOF-4272 inhibits the de novo biosynthesis of uric acid by blocking the xanthine oxidase/xanthine dehydrogenase system. 2, 3) However, NBMPR, an inhibitor of the plasma membrane equilibrative (Na ＋ -independent, facilitated diŠusion) nucleoside transporter, 16) had no signiˆcant eŠect on the uptake rate of either enantiomer.
The decrease in LDH latency observed with metabolic inhibitors such as antimycin, oligomycin, rotenone, CCCP, and FCCP suggests hepatic injury resulting from inhibition of the energy supply ( Table  2) . However, the inhibition of the hepatic uptake was not due to a lethal cytotoxic eŠect of inhibitors, because cell viability, as estimated by LDH latency, was 
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The eŠects of temperature, SH -modifying reagents, and DIDS, a potent inhibitor of the anion exchanger, 17) on the initial hepatic uptake rate of BOF-4272 at 5 mM are shown in Fig. 5 . PCMBS and PCMB (a poorly permeable SH reagent and a highly permeable SH reagent, respectively) 18) had no signiˆcant eŠects on the uptake rate of either enantiomer. DIDS inhibited the hepatic uptake of the S(-) enantiomer to a greater degree than it inhibited the hepatic uptake of the R(＋) enantiomer.
BOF-4272 is present as an organic anion in the body. We therefore investigated the eŠects of organic anions on the initial hepatic uptake rate of BOF-4272 at 5 mM (Fig. 6) . Organic anions such as TCA and CA reduced the uptake of both enantiomers. However, there were no signiˆcant diŠerences in the percent uptake of the two enantiomers in the presence of these organic anions. PBC and b-lactam antibiotics were transported by the same carrier-mediated transport system through the plasma membrane and was actively uptaken into hepatocytes, 18) but neither of the enantiomers was aŠected by PBC. The eŠects of enantiomer-enantiomer interactions on the hepatic uptake of BOF-4272 are shown Fig. 7 . The in‰uence of distomer on the hepatic up-take rate of the S(-) enantiomer was greater than that on the hepatic uptake rate of the R(＋) enantiomer.
In conclusion, we found that the hepatic uptake of both BOF-4272 enantiomers is not due to simple diŠusion but involves carrier-mediated uptake. We suggest that the carrier-mediated uptake of BOF-4272 enantiomers includes both NBMPR-insensitive facilitated diŠusion and active transport, and that the enantioselective uptake of BOF-4272 is due to diŠer-ences in a‹nity for the active transporter.
